Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Erika Ferraro
Institutions:
University of New Mexico,
University of New Mexico Health Sciences Center
Observed institutions:
University of New Mexico,
Bambino Gesù Children's Hospital,
Istituti di Ricovero e Cura a Carattere Scientifico,
University of New Mexico Health Sciences Center,
Sapienza University of Rome
ORCID:
0009-0005-4825-061X
Observed ORCID:
0009-0005-4825-061X
OpenAlex ID:
A5108910797
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3–FOXO1 rhabdomyosarcoma
2025
·
Francesca Antonella Aiello
, Lucrezia D’Archivio
, et al.
·
Cell Death Discovery
·
5
PDF
Inhibition of bromodomain and extra-terminal motif (BET) proteins in pediatric sarcoma: A systematic review of in vitro and in vivo studies
2025
·
Erika Ferraro
, Elisa Macrì
, et al.
·
Drug Discovery Today
·
3
Translation of chronic pelvic pain experience into patient treatment preference profiles with Q-methodology
2026
·
Kate V. Meriwether
, Melissa Constantine
, et al.
·
American Journal of Obstetrics and Gynecology
Ritonavir and DNA Damage: A New Perspective on an Old Drug
2025
·
Silvia Pomella
, Erika Ferraro
, et al.
·
Applied Sciences
PDF
Abstract B013: Uncovering and targeting resistance mechanisms to BET inhibitors in pediatric Fusion-Positive Rhabdomyosarcoma
2025
·
Erika Ferraro
, Elisa Macrí
, et al.
·
Cancer Research
Inhibition of Bromodomain and Extra-terminal motif (BET) proteins in pediatric sarcoma: a systematic review of in vitro and in vivo studies
2025
·
Erika Ferraro
, Elisa Macrì
, et al.
PDF
Abstract 4739: Targeting resistance to BET inhibitors in Fusion-Positive Rhabdomyosarcoma
2024
·
Matteo Cassandri
, Erika Ferraro
, et al.
·
Cancer Research
Show more works
View as search
Works count:
7
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type